Page last updated: 2024-08-22

metoprine and levoleucovorin

metoprine has been researched along with levoleucovorin in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-199014 (93.33)18.7374
1990's1 (6.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldie, JH; Hill, BT; Price, LA2
Cavallito, JC; Nichol, CA; Sigel, CW; Woolley, JL1
Hansen, HH; Hansen, M; Lau, ME1
Brown, OE; Frazer, T; Kutler, M; Laszlo, J; Sedwick, WD1
Alberto, P; Beretta-Piccoli, M; Medenica, R; Peytremann, R1
Roos, DS; Schimke, RT1
Browman, GP; Calvert, AH; Harrap, KR; Hart, LI; Taylor, GA1
Alberto, P; Brugarolas, A; Cavalli, F; Hansen, HH; Klepp, O; Renard, J1
de Jager, R; Dorlet, C; Dupont, D; Lagrange, G; Rodzynek, JJ1
Brugarolas, A; de Jager, R; Hansen, M1
Casper, ES; Golbey, RB; Gralla, RJ; Kelsen, DP; Lynch, GR; Stoopler, MB1
Currie, V; Kemeny, N; Lynch, G1
Hill, BT; Price, LA1
Assaraf, YG; Slotky, JI1

Trials

1 trial(s) available for metoprine and levoleucovorin

ArticleYear
Initial clinical experience with a simultaneous combination of 2,4-diamino-5(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) with folinic acid.
    Cancer chemotherapy and pharmacology, 1978, Volume: 1, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasms; Pyrimethamine

1978

Other Studies

14 other study(ies) available for metoprine and levoleucovorin

ArticleYear
Methodichlorophen as anti-tumor drug.
    British medical journal, 1975, Apr-05, Volume: 2, Issue:5961

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bone Marrow Diseases; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chlorobenzenes; Drug Therapy, Combination; Erythema; Headache; Humans; Kidney Neoplasms; Leucovorin; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Middle Aged; Neoplasms; Pyrimethamine; Pyrimidines; Teratoma; Testicular Neoplasms

1975
Lipid-soluble diaminopyrimidine inhibitors of dihydrofolate reductase.
    Cancer treatment reports, 1977, Volume: 61, Issue:4

    Topics: Administration, Oral; Animals; Brain; Brain Neoplasms; Dogs; Folic Acid; Folic Acid Antagonists; Half-Life; Humans; Leucovorin; Lipid Metabolism; Male; Models, Biological; Pyrimethamine; Pyrimidines; Rats; Solubility; Species Specificity

1977
DDMP and selective folinic acid protection in the treatment of malignant disease: a further report.
    Clinical oncology, 1977, Volume: 3, Issue:3

    Topics: Bone Marrow; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Neoplasms; Pyrimethamine; Remission, Spontaneous

1977
Unpredictable hematologic toxicity of weekly ddmp.
    Cancer treatment reports, 1978, Volume: 62, Issue:5

    Topics: Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Folic Acid; Hematologic Diseases; Humans; Leucovorin; Middle Aged; Pyrimethamine

1978
New dose-time relationships of folate antagonists to sustain inhibition of human lymphoblasts and leukemic cells in vitro.
    Cancer research, 1979, Volume: 39, Issue:9

    Topics: Cell Line; Cell Survival; Deoxyuridine; Dose-Response Relationship, Drug; Folic Acid Antagonists; Humans; Leucovorin; Leukemia; Methotrexate; Pyrimethamine; Time Factors

1979
Toxicity of folic acid analogs in cultured human cells: a microtiter assay for the analysis of drug competition.
    Proceedings of the National Academy of Sciences of the United States of America, 1987, Volume: 84, Issue:14

    Topics: Animals; Cell Division; Cell Line; Drug Interactions; Drug Resistance; Gene Amplification; Humans; Leucovorin; Methotrexate; Mice; Pyrimethamine; Pyrimidines; Tetrahydrofolate Dehydrogenase; Xeroderma Pigmentosum

1987
The intracellular mechanism of action of metoprine (DDMP).
    European journal of cancer, 1980, Volume: 16, Issue:12

    Topics: Animals; Cell Survival; Cells, Cultured; Deoxyuridine; Dose-Response Relationship, Drug; Drug Resistance; Folic Acid Antagonists; Leucovorin; Leukemia L1210; Methotrexate; Mice; Purines; Pyrimethamine; Pyrimidines; Thymidine

1980
Phase II study of diamino-dichlorophenyl-methylpyrimidine (DDMP) with folinic acid (CF) protection and rescue.
    European journal of cancer, 1980, Volume: 16, Issue:9

    Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Child; Drug Evaluation; Drug Therapy, Combination; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Leucovorin; Leukocyte Count; Melanoma; Neoplasms; Platelet Count; Pyrimethamine; Sarcoma

1980
Phase I clinical trial and pharmacology of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (metoprine) (DDMP) and folinic acid (CF).
    Cancer chemotherapy and pharmacology, 1981, Volume: 6, Issue:1

    Topics: Antineoplastic Agents; Drug Evaluation; Humans; Kinetics; Leucovorin; Neoplasms; Protein Binding; Pyrimethamine

1981
Phase II clinical trial of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine) and folinic acid (CF) in solid tumors.
    Cancer chemotherapy and pharmacology, 1981, Volume: 6, Issue:1

    Topics: Antineoplastic Agents; Bone Marrow Diseases; Drug Evaluation; Humans; Leucovorin; Neoplasms; Pyrimethamine

1981
Phase II evaluation of metoprine in patients with non-small-cell lung carcinoma.
    Cancer clinical trials, 1981,Fall, Volume: 4, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Pyrimethamine

1981
Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.
    Cancer clinical trials, 1981,Fall, Volume: 4, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Pyrimethamine; Rectal Neoplasms

1981
An experimentally designed high dose simultaneous combination of a diaminopyrimidine and folinic acid for the treatment of human malignancies.
    European journal of cancer & clinical oncology, 1981, Volume: 17, Issue:8

    Topics: Antineoplastic Agents; Bone Marrow Diseases; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leucovorin; Neoplasms; Pyrimethamine

1981
Characterization of a lipophilic antifolate resistance provoked by treatment of mammalian cells with the antiparasitic agent pyrimethamine.
    The Journal of biological chemistry, 1993, Feb-25, Volume: 268, Issue:6

    Topics: Animals; Cell Survival; CHO Cells; Cricetinae; Drug Resistance; Flow Cytometry; Folic Acid Antagonists; Leucovorin; Pyrimethamine; RNA, Messenger; Tetrahydrofolate Dehydrogenase; Trimethoprim

1993